SV Health Investors is a venture capital firm in Massachusetts that focuses on biotechnology and healthcare industry. Founded 1993 in Boston, Massachusetts, United States, it invests in debt, early stage ventures, late stage ventures, series B, series A, and series D rounds. Its portfolio companies include Xilio Therapeutics, EBT Medical, Ervaxx, Healthify, Clarify Medical, Bardy Diagnostics, CSA Medical, Rheostat Therapeutics, Ribometrix, and Urgent Team Holdings, Inc. As of April 2020, SV Health Investors has made 216 investments. Their most recent investment was on March 2, 2020, when Xilio Therapeutics raised $100.5M. V Health Investors has had 38 exits, the most notable of which include Bicycle Therapeutics, Avrobio, and Sutro Biopharma. The company has raised seven funds, their latest being SV7 Growth Fund.